- Home
- VCSA vs RANI Comparison
VCSA vs RANI Comparison
Compare VCSA & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCSA
- RANI
- Stock Information
- Founded
- VCSA 2009
- RANI 2012
- Country
- VCSA United States
- RANI United States
- Employees
- VCSA N/A
- RANI N/A
- Industry
- VCSA Computer Software: Prepackaged Software
- RANI Medicinal Chemicals and Botanical Products
- Sector
- VCSA Technology
- RANI Health Care
- Exchange
- VCSA Nasdaq
- RANI Nasdaq
- Market Cap
- VCSA 38.6M
- RANI 41.6M
- IPO Year
- VCSA N/A
- RANI 2021
- Fundamental
- Price
- VCSA $5.01
- RANI $1.49
- Analyst Decision
- VCSA Hold
- RANI Strong Buy
- Analyst Count
- VCSA 4
- RANI 5
- Target Price
- VCSA $7.50
- RANI $11.80
- AVG Volume (30 Days)
- VCSA 357.7K
- RANI 360.6K
- Earning Date
- VCSA 02-26-2025
- RANI 11-14-2024
- Dividend Yield
- VCSA N/A
- RANI N/A
- EPS Growth
- VCSA N/A
- RANI N/A
- EPS
- VCSA N/A
- RANI N/A
- Revenue
- VCSA $949,936,000.00
- RANI N/A
- Revenue This Year
- VCSA N/A
- RANI N/A
- Revenue Next Year
- VCSA N/A
- RANI N/A
- P/E Ratio
- VCSA N/A
- RANI N/A
- Revenue Growth
- VCSA N/A
- RANI N/A
- 52 Week Low
- VCSA $2.07
- RANI $1.24
- 52 Week High
- VCSA $11.70
- RANI $8.75
- Technical
- Relative Strength Index (RSI)
- VCSA 66.93
- RANI 49.69
- Support Level
- VCSA $4.95
- RANI $1.24
- Resistance Level
- VCSA $5.17
- RANI $1.61
- Average True Range (ATR)
- VCSA 0.13
- RANI 0.11
- MACD
- VCSA -0.01
- RANI 0.03
- Stochastic Oscillator
- VCSA 65.93
- RANI 67.57
About VCSA Vacasa Inc.
Vacasa Inc is a vacation rental management platform in North America, transforming the vacation rental experience by integrating purpose-built technology with expert local and national teams.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.